• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺功能减退症中骨骼的动态和结构特性

Dynamic and structural properties of the skeleton in hypoparathyroidism.

作者信息

Rubin Mishaela R, Dempster David W, Zhou Hua, Shane Elizabeth, Nickolas Thomas, Sliney James, Silverberg Shonni J, Bilezikian John P

机构信息

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

出版信息

J Bone Miner Res. 2008 Dec;23(12):2018-24. doi: 10.1359/jbmr.080803.

DOI:10.1359/jbmr.080803
PMID:18684087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2686925/
Abstract

Hypoparathyroidism, a disorder in which PTH is absent, is associated with BMD that is above average. We studied associated structural and dynamic properties of the skeleton in hypoparathyroidism. Thirty-three subjects with hypoparathyroidism and 33 age- and sex-matched control subjects with no known metabolic diseases underwent percutaneous iliac crest bone biopsies after double-labeling with tetracycline. The main outcome was histomorphometric assessment of structural and dynamic skeletal parameters. Subjects with hypoparathyroidism had greater cancellous bone volume (mean +/- SD; BV/TV: 23.5 +/- 8 versus 19.7 +/- 5%, p = 0.02), trabecular width (Tb.Wi: 136.1 +/- 37 versus 119.3 +/- 21 microm, p = 0.03), and cortical width (Ct.Wi: 923.4 +/- 420 versus 753.5 +/- 246 microm, p = 0.05) than control subjects. Dynamic skeletal indices, including mineralizing surface (MS: 0.85 +/- 1.58 versus 4.27 +/- 3.32%, p < 0.0001) and bone formation rate (BFR/BS: 0.006 +/- 0.014 versus 0.032 +/- 0.028 microm(3)/microm(2)/d, p < 0.0001), were profoundly suppressed in the hypoparathyroid subjects. We conclude that hypoparathyroidism is characterized by markedly unusual structural and dynamic properties of bone.

摘要

甲状旁腺功能减退症是一种甲状旁腺激素缺乏的疾病,与高于平均水平的骨密度相关。我们研究了甲状旁腺功能减退症患者骨骼的相关结构和动态特性。33例甲状旁腺功能减退症患者和33例年龄及性别匹配、无已知代谢疾病的对照受试者,在使用四环素进行双重标记后,接受了经皮髂嵴骨活检。主要观察指标是对骨骼结构和动态参数进行组织形态计量学评估。甲状旁腺功能减退症患者的骨小梁体积更大(均值±标准差;骨小梁体积/总体积:23.5±8%对19.7±5%,p = 0.02)、骨小梁宽度更大(Tb.Wi:136.1±37对119.3±21微米,p = 0.03)以及皮质宽度更大(Ct.Wi:923.4±420对753.5±246微米,p = 0.05)。与对照受试者相比,甲状旁腺功能减退症患者的动态骨骼指标,包括矿化表面(MS:0.85±1.58%对4.27±3.32%,p < 0.0001)和骨形成率(BFR/BS:0.006±0.014对0.032±0.028立方微米/平方微米/天,p < 0.0001)受到显著抑制。我们得出结论,甲状旁腺功能减退症的特征是骨骼具有明显异常的结构和动态特性。

相似文献

1
Dynamic and structural properties of the skeleton in hypoparathyroidism.甲状旁腺功能减退症中骨骼的动态和结构特性
J Bone Miner Res. 2008 Dec;23(12):2018-24. doi: 10.1359/jbmr.080803.
2
Three dimensional cancellous bone structure in hypoparathyroidism.甲状旁腺功能减退症的三维松质骨结构。
Bone. 2010 Jan;46(1):190-5. doi: 10.1016/j.bone.2009.09.020. Epub 2009 Sep 25.
3
PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.甲状旁腺激素(1-84)治疗可逆转甲状旁腺功能减退症中的异常骨重塑动力学和结构。
J Bone Miner Res. 2011 Nov;26(11):2727-36. doi: 10.1002/jbmr.452.
4
Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.甲状旁腺功能减退症:临床特征、骨骼微观结构及甲状旁腺激素替代治疗
Arq Bras Endocrinol Metabol. 2010 Mar;54(2):220-6. doi: 10.1590/s0004-27302010000200019.
5
The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.甲状旁腺功能减退症患者长期给予 rhPTH(1-84)治疗的骨组织形态计量学研究
J Bone Miner Res. 2018 Nov;33(11):1931-1939. doi: 10.1002/jbmr.3543. Epub 2018 Aug 16.
6
Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism.甲状旁腺激素给药对甲状旁腺功能减退症患者骨强度的影响。
J Bone Miner Res. 2016 May;31(5):1082-8. doi: 10.1002/jbmr.2777. Epub 2016 Jan 24.
7
A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.干梅补充剂和 PTH 治疗对成年骨质疏松去卵巢大鼠骨代谢反应的比较研究。
Bone. 2014 Jan;58:151-9. doi: 10.1016/j.bone.2013.10.005. Epub 2013 Oct 11.
8
Histomorphometric features of bone in patients with primary and secondary hypoparathyroidism.
Kidney Int. 2003 May;63(5):1809-16. doi: 10.1046/j.1523-1755.2003.00916.x.
9
PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.甲状旁腺功能减退症患者给予全段甲状旁腺激素(1-84)可短暂降低骨基质矿化。
J Bone Miner Res. 2016 Jan;31(1):180-9. doi: 10.1002/jbmr.2588. Epub 2015 Jul 28.
10
The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.原发性甲状旁腺功能亢进症中骨的组织形态计量学:松质骨结构的保留
J Clin Endocrinol Metab. 1990 Apr;70(4):930-8. doi: 10.1210/jcem-70-4-930.

引用本文的文献

1
The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review.间歇性甲状旁腺激素治疗对人体骨重塑和骨建模的细胞效应——一项以组织形态计量学为核心的综述
Osteoporos Int. 2025 Sep 9. doi: 10.1007/s00198-025-07612-z.
2
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.再探甲状旁腺疾病中的骨:来自流行病学、手术及新药疗效的证据
Endocr Rev. 2025 Jul 15;46(4):576-620. doi: 10.1210/endrev/bnaf010.
3
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR).慢性甲状旁腺功能减退症患者的骨骼健康状况:来自加拿大国家甲状旁腺功能减退症登记处(CNHR)的结果。
Osteoporos Int. 2025 Apr;36(4):673-684. doi: 10.1007/s00198-025-07410-7. Epub 2025 Feb 16.
4
Hypoparathyroidism: diagnosis, management and emerging therapies.甲状旁腺功能减退症:诊断、管理及新出现的治疗方法。
Nat Rev Endocrinol. 2025 Jun;21(6):360-374. doi: 10.1038/s41574-024-01075-8. Epub 2025 Feb 4.
5
Bone Microstructure and Bone Strength Among Patients with Pseudohypoparathyroidism.假性甲状旁腺功能减退症患者的骨微结构与骨强度
Calcif Tissue Int. 2024 Dec 14;116(1):4. doi: 10.1007/s00223-024-01313-1.
6
Preclinical development of EXT608, an investigational parathyroid hormone derivative with extended half-life for the treatment of hypoparathyroidism.EXT608的临床前开发,EXT608是一种研究性甲状旁腺激素衍生物,半衰期延长,用于治疗甲状旁腺功能减退症。
JBMR Plus. 2024 Apr 18;8(6):ziae045. doi: 10.1093/jbmrpl/ziae045. eCollection 2024 Jun.
7
Incident comorbidities in patients with chronic hypoparathyroidism after thyroidectomy: a multicenter nationwide study.甲状腺切除术后慢性甲状旁腺功能减退症患者的并发疾病:一项多中心全国性研究。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1348971. doi: 10.3389/fendo.2024.1348971. eCollection 2024.
8
Hypoparathyroidism: Musculoskeletal Manifestations Related to Parathormone Deficiency.甲状旁腺功能减退症:与甲状旁腺激素缺乏相关的肌肉骨骼表现。
Curr Rheumatol Rev. 2024;20(5):488-500. doi: 10.2174/0115733971267895231227102539.
9
Barakat syndrome diagnosed decades after initial presentation.巴拉卡特综合征在首次出现数十年后才得以诊断。
Endocrinol Diabetes Metab Case Rep. 2023 Dec 20;2023(4). doi: 10.1530/EDM-23-0018. Print 2023 Oct 1.
10
Hypocalcemia in combination with hyperphosphatemia impairs muscle cell differentiation in vitro.低钙血症与高磷血症结合会损害体外肌细胞分化。
J Endocrinol Invest. 2024 Apr;47(4):947-957. doi: 10.1007/s40618-023-02212-2. Epub 2023 Oct 11.

本文引用的文献

1
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.成骨细胞衍生的甲状旁腺激素相关蛋白是一种有效的内源性骨合成代谢因子,可改变所给予的甲状旁腺激素1-34的治疗效果。
J Clin Invest. 2005 Sep;115(9):2402-11. doi: 10.1172/JCI24918.
2
Osteoblast-derived PTHrP is a physiological regulator of bone formation.成骨细胞衍生的甲状旁腺激素相关蛋白是骨形成的生理调节因子。
J Clin Invest. 2005 Sep;115(9):2322-4. doi: 10.1172/JCI26239.
3
Impact of parathyroid status and Ca and vitamin-D supplementation on bone mass and muscle-bone relationships in 208 Belarussian children after thyroidectomy because of thyroid carcinoma.甲状旁腺状态以及钙和维生素D补充对208例因甲状腺癌行甲状腺切除术后的白俄罗斯儿童骨量及肌肉-骨骼关系的影响
Exp Clin Endocrinol Diabetes. 2004 Sep;112(8):444-50. doi: 10.1055/s-2004-821204.
4
Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism.钙敏感受体自身抗体是获得性甲状旁腺功能减退症的相关标志物。
J Clin Endocrinol Metab. 2004 Sep;89(9):4484-8. doi: 10.1210/jc.2004-0021.
5
Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice.甲状旁腺激素相关肽是甲状旁腺激素缺失小鼠小梁骨体积增加所必需的。
Endocrinology. 2004 Aug;145(8):3554-62. doi: 10.1210/en.2003-1695. Epub 2004 Apr 16.
6
Skeletal abnormalities in Pth-null mice are influenced by dietary calcium.甲状旁腺激素基因敲除小鼠的骨骼异常受饮食中钙的影响。
Endocrinology. 2004 Apr;145(4):2046-53. doi: 10.1210/en.2003-1097. Epub 2003 Dec 30.
7
Is the paradigm shifting?范式正在转变吗?
Bone. 2003 Oct;33(4):457-65. doi: 10.1016/s8756-3282(03)00236-9.
8
Bone microarchitecture assessment: current and future trends.骨微结构评估:现状与未来趋势
Osteoporos Int. 2003 Sep;14 Suppl 5:S89-95; discussion S95-9. doi: 10.1007/s00198-003-1479-z. Epub 2003 Aug 29.
9
Microdamage and bone strength.微损伤与骨强度
Osteoporos Int. 2003 Sep;14 Suppl 5:S67-72. doi: 10.1007/s00198-003-1476-2. Epub 2003 Aug 29.
10
Bone microarchitecture and strength.骨微结构与强度
Osteoporos Int. 2003 Sep;14 Suppl 5:S54-6. doi: 10.1007/s00198-003-1474-4. Epub 2003 Aug 29.